These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 27442671)
1. Potential harmful correlation between homocysteine and low-density lipoprotein cholesterol in patients with hypothyroidism. Dong X; Yao Z; Hu Y; Yang N; Gao X; Xu Y; Wang G Medicine (Baltimore); 2016 Jul; 95(29):e4291. PubMed ID: 27442671 [TBL] [Abstract][Full Text] [Related]
2. Homocysteine diminishes apolipoprotein A-I function and expression in patients with hypothyroidism: a cross-sectional study. Yang N; Yao Z; Miao L; Liu J; Gao X; Xu Y; Wang G Lipids Health Dis; 2016 Jul; 15():123. PubMed ID: 27457726 [TBL] [Abstract][Full Text] [Related]
3. Novel Clinical Evidence of an Association between Homocysteine and Insulin Resistance in Patients with Hypothyroidism or Subclinical Hypothyroidism. Yang N; Yao Z; Miao L; Liu J; Gao X; Fan H; Hu Y; Zhang H; Xu Y; Qu A; Wang G PLoS One; 2015; 10(5):e0125922. PubMed ID: 25938439 [TBL] [Abstract][Full Text] [Related]
4. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [TBL] [Abstract][Full Text] [Related]
5. Effects of L-thyroxine treatment on early markers of atherosclerotic disease in children with subclinical hypothyroidism. Cerbone M; Capalbo D; Wasniewska M; Alfano S; Mattace Raso G; Oliviero U; Cittadini A; De Luca F; Salerno M Eur J Endocrinol; 2016 Jul; 175(1):11-9. PubMed ID: 27068687 [TBL] [Abstract][Full Text] [Related]
7. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes. Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165 [TBL] [Abstract][Full Text] [Related]
8. Effects of chemerin and homocysteine levels and their associations with occurrence and development of ischemic cerebrovascular disease. Wang L; Jia J; Hong Z; Zhang L; Zhang J Lipids Health Dis; 2021 Sep; 20(1):108. PubMed ID: 34544451 [TBL] [Abstract][Full Text] [Related]
10. Relationship between plasma homocysteine level and lipid profiles in a community-based Chinese population. Momin M; Jia J; Fan F; Li J; Dou J; Chen D; Huo Y; Zhang Y Lipids Health Dis; 2017 Mar; 16(1):54. PubMed ID: 28288621 [TBL] [Abstract][Full Text] [Related]
11. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study. Iqbal A; Jorde R; Figenschau Y J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979 [TBL] [Abstract][Full Text] [Related]
12. Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients. Hu Y; Liu J; Dong X; Xu Y; Leng S; Wang G Med Sci Monit; 2016 Nov; 22():4146-4151. PubMed ID: 27803497 [TBL] [Abstract][Full Text] [Related]
13. Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: response to L-T(4) treatment. Brenta G; Berg G; Arias P; Zago V; Schnitman M; Muzzio ML; Sinay I; Schreier L Thyroid; 2007 May; 17(5):453-60. PubMed ID: 17542675 [TBL] [Abstract][Full Text] [Related]
14. Relevance of different apolipoprotein content in binding of homocysteine to plasma lipoproteins. Ventura P; Panini R; Rosa MC; Gaetti E; Salvioli G Nutr Metab Cardiovasc Dis; 2003 Aug; 13(4):218-26. PubMed ID: 14650354 [TBL] [Abstract][Full Text] [Related]
15. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. Tzotzas T; Krassas GE; Konstantinidis T; Bougoulia M Thyroid; 2000 Sep; 10(9):803-8. PubMed ID: 11041458 [TBL] [Abstract][Full Text] [Related]
16. Association Between Cardiovascular Risk Factors and Serum Thyrotropin Concentration Among Healthy Chinese Subjects and Subjects with Unsuspected Subclinical Hypothyroidism. Wu J; Tao Y; Gu H; Sui J Clin Lab; 2016; 62(5):807-14. PubMed ID: 27349005 [TBL] [Abstract][Full Text] [Related]
17. Levothyroxine treatment restored the decreased circulating fibroblast growth factor 21 levels in patients with hypothyroidism. Wang G; Liu J; Yang N; Hu Y; Zhang H; Miao L; Yao Z; Xu Y Eur J Intern Med; 2016 Jun; 31():94-8. PubMed ID: 27085392 [TBL] [Abstract][Full Text] [Related]
18. Elevated serum lipoprotein(a) in subclinical hypothyroidism. Kung AW; Pang RW; Janus ED Clin Endocrinol (Oxf); 1995 Oct; 43(4):445-9. PubMed ID: 7586619 [TBL] [Abstract][Full Text] [Related]
19. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy. Arem R; Patsch W Arch Intern Med; 1990 Oct; 150(10):2097-100. PubMed ID: 2222095 [TBL] [Abstract][Full Text] [Related]
20. Plasma Homocysteine Level Is Independently Associated With Conventional Atherogenic Lipid Profile and Remnant Cholesterol in Adults. Zhou L; Liu J; An Y; Wang Y; Wang G Front Cardiovasc Med; 2022; 9():898305. PubMed ID: 35770226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]